Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute and chronic viral hepatitis

R Scheig1

  • 1State University of New York at Buffalo, USA.

Lippincott'S Primary Care Practice
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Viral hepatitis, including A, B, and C, affects many in the US. Prevention through education and immunization is key to combating these infections and their chronic complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of tests used to screen patients with liver disorders.

Primary care·1996
Same author

Recurrent abdominal pain in a patient with cystic fibrosis and type IV hyperlipidemia.

Journal of pediatric gastroenterology and nutrition·1995
Same author

That demon rum.

The American journal of gastroenterology·1991
Same author

Normal hepatic function foiled by HBV infection after liver transplantation.

The American journal of gastroenterology·1990
Same author

Immunologic abnormalities in alcoholic liver disease.

The American journal of gastroenterology·1990
Same author

Defenestration of hepatic sinusoids in the pathogenesis of alcoholic hyperlipoproteinemia.

Hepatology (Baltimore, Md.)·1990

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Viral hepatitis (A, B, C, D, E, G) represents a significant global health burden.
  • High incidence rates in the US include 32,000 Hepatitis A, 300,000 Hepatitis B, and 150,000 Hepatitis C cases annually.
  • Risk factors encompass sexual activity, IV drug use, body modifications, occupational exposure, and transfusions.

Purpose of the Study:

  • To highlight the epidemiology and risk factors of viral hepatitis.
  • To emphasize the importance of diagnostic markers for differentiating hepatitis types and infection chronicity.
  • To discuss current treatment limitations and the need for novel therapeutic strategies.

Main Methods:

  • Review of epidemiological data on viral hepatitis incidence in the United States.

Related Experiment Videos

  • Analysis of risk factors associated with hepatitis virus transmission.
  • Examination of diagnostic approaches for hepatitis classification.
  • Assessment of current therapeutic interventions and ongoing clinical trials.

    • Main Results:

    • Hepatitis B and C infections can lead to chronic carriage in 5% and up to 80% of cases, respectively.
    • Chronic Hepatitis C infection may progress to cirrhosis and hepatocellular carcinoma over approximately 10 years.
    • Interferon-alpha is the sole FDA-approved treatment for chronic Hepatitis B and C, with frequent relapses in Hepatitis C.

    Conclusions:

    • Effective prevention strategies, including patient education on high-risk behaviors and vaccination, are crucial.
    • Development of new antivirals and combination therapies is essential to improve outcomes for chronic hepatitis B and C.
    • Early diagnosis and management are vital to mitigate long-term complications of viral hepatitis.